Staged AMI Detection System Using Physiological Signals
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing medical devices face challenges in detecting acute myocardial infarction (AMI) with satisfactory sensitivity and specificity, leading to delayed recognition and treatment.
Innovation Solution
A staged approach for AMI detection involving sensing physiological signals, deriving parameters, and collecting additional information to reach a predefined confidence level, with the system including implantable or external medical devices equipped with sensors and processing circuitry to compute probabilities and prompt patient queries for symptom verification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional AMI detection criteria (ischemic chest pain, ECG findings, raised CK concentrations) are used, then the diagnosis can be established, but the detection sensitivity and specificity are insufficient leading to delayed recognition
Solution Approach 1:
The detection process is segmented into multiple stages: initial detection using ECG parameters (ST-segment deviation, T-wave inversion), followed by secondary confirmation using additional physiological parameters (heart rate variability, respiratory rate, body temperature) and patient symptom assessment. This staged approach improves detection accuracy while enabling timely recognition by acting on the first stage results immediately.
Solution Approach 2:
The system performs preliminary detection using continuously monitored ECG parameters and compares them against predefined thresholds for AMI indicators. When threshold violations occur, the system proactively initiates the detection algorithm and prepares for immediate alert generation, reducing the time to recognition by acting in advance rather than waiting for traditional criterion fulfillment.
2Measurement precision
If additional physiological parameters and patient symptoms are collected to improve detection accuracy, then AMI detection specificity increases, but the system complexity increases
Solution Approach 1:
The detection system leverages multi-functionality by using a single implantable device to perform multiple roles: continuous ECG monitoring, additional physiological parameter sensing (heart rate variability, respiratory rate, body temperature), patient symptom assessment through integrated interfaces, and alert generation. This consolidates what would otherwise require multiple separate systems into one unified device, improving specificity without proportionally increasing complexity.
Solution Approach 2:
The system incorporates automated processing where the device itself performs the detection algorithm, compares parameters against thresholds, determines when AMI criteria are met, and generates alerts autonomously. This self-service capability reduces the need for complex external processing systems and manual assessment, thereby improving detection specificity while managing system complexity through automation.
3Reliability
If a staged approach with multiple detection stages is implemented, then false alerts are minimized, but the detection time may be extended
Solution Approach 1:
The system dynamically adjusts the detection process based on risk stratification. High-risk patients or those with multiple threshold violations trigger immediate alert generation with reduced confirmation requirements, while lower-risk cases undergo the full multi-stage verification process. This dynamic approach minimizes false alerts through verification when needed while reducing detection time for high-confidence cases, resolving the contradiction between reliability and speed.
Solution Approach 2:
The system changes detection parameters and thresholds based on the detection stage and patient risk profile. In early stages, more stringent criteria are applied to reduce false alerts, while in later confirmation stages, additional parameters are evaluated. The system also adjusts sensitivity thresholds based on population characteristics and individual patient history, optimizing the balance between false alert reduction and detection speed for different clinical scenarios.
Data Source
AI summary
A system and method are provided for the detection of acute myocardial infarction (AMI) using a staged approach for accurate and rapid detection. Physiological signals in a patient's body are sensed and corresponding physiological parameters are derived in a staged approach in order to determine the probability that AMI is occurring in a patient in a first detection stage. If the computed probability from physiological signals indicates the possibility of AMI, then the patient is prompted, such as through a patient-wearable device, to answer specific AMI-related questions to assist in diagnosis of AMI in a second stage. AMI is detected when the computed probability in the second stage exceeds a predefined detection threshold. A patient or physician alert may then be generated, which may further include the transfer of data via a communication link or network, in response to an AMI detection signal.